Pharmaceutical companies in the United States by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 44 pharmaceutical companies in the United States ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 20 Nov 2026, 07:26 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Erasca+395%
- Median
- +27.7%
- Combined market value
- TRY 188.93T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | TRY 252.4B | TRY 719.13 | 3.34% up | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | TRY 468.9B | TRY 4,937.31 | 3.77% down | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | TRY 334.7B | TRY 4,934.27 | 1.91% up | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | TRY 265.4B | TRY 6,290.60 | 0.38% down | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | TRY 204.1B | TRY 1,490.85 | 1.24% up | 168% up | ||
| 6 | TG TherapeuticsTGTX · Health Care | +117% | TRY 495.9B | TRY 3,281.09 | 1.88% down | 117% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +108% | TRY 241.6B | TRY 4,289.99 | 1.01% up | 108% up | ||
| 8 | ViatrisVTRS · Health Care | +99.0% | TRY 1.15T | TRY 1,005.36 | 1.97% down | 99% up | ||
| 9 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | TRY 376.9B | TRY 1,081.73 | 2.24% down | 90% up | ||
| 10 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | TRY 439.5B | TRY 15,722.71 | 1.87% up | 86% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | TRY 227.9B | TRY 2,082.03 | 0.48% down | 86% up | ||
| 12 | Royalty PharmaRPRX · Health Care | +78.9% | TRY 1.97T | TRY 3,424.71 | 1.38% down | 79% up | ||
| 13 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | TRY 409.4B | TRY 6,271.89 | 2.47% down | 51% up | ||
| 14 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | TRY 290.3B | TRY 14,511.01 | 3.94% down | 50% up | ||
| 15 | Merck & CoMRK · Health Care | +45.1% | TRY 16.56T | TRY 6,716.41 | 3.61% down | 45% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | +44.7% | TRY 234.5B | TRY 2,442.61 | 3.86% down | 45% up | ||
| 17 | Belite BioBLTE · Health Care | +43.1% | TRY 310.2B | TRY 7,637.32 | 3.33% down | 43% up | ||
| 18 | Johnson & JohnsonJNJ · Health Care | +34.3% | TRY 32.52T | TRY 13,509.70 | 2.04% down | 34% up | ||
| 19 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | TRY 315.3B | TRY 4,830.09 | 3.27% up | 34% up | ||
| 20 | Eli LillyLLY · Health Care | +32.5% | TRY 60.86T | TRY 68,328.30 | 2.29% down | 33% up | ||
| 21 | Bristol-Myers SquibbBMY · Health Care | +29.6% | TRY 6.03T | TRY 2,950.35 | 2.05% down | 30% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | TRY 4.83T | TRY 46,694.78 | 2.35% down | 28% up | ||
| 23 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | TRY 6.68T | TRY 26,330.61 | 2.94% down | 27% up | ||
| 24 | Elanco Animal HealthELAN · Health Care | +25.7% | TRY 664.5B | TRY 1,329.53 | 1.54% down | 26% up | ||
| 25 | AbbVieABBV · Health Care | +24.7% | TRY 25.35T | TRY 14,339.07 | 0.86% down | 25% up | ||
| 26 | United TherapeuticsUTHR · Health Care | +21.6% | TRY 1.2T | TRY 28,274.58 | 3.16% down | 22% up | ||
| 27 | BridgeBio PharmaBBIO · Health Care | +20.7% | TRY 770.2B | TRY 3,953.69 | 0.22% up | 21% up | ||
| 28 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | TRY 409.5B | TRY 5,906.76 | 1.88% down | 18% up | ||
| 29 | BioMarin PharmaceuticalBMRN · Health Care | +17.1% | TRY 601.6B | TRY 3,106.11 | 0.02% down | 17% up | ||
| 30 | PfizerPFE · Health Care | +15.0% | TRY 7.94T | TRY 1,392.74 | 1.85% down | 15% up | ||
| 31 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | TRY 312.1B | TRY 2,207.45 | 1.25% up | 13% up | ||
| 32 | Axsome TherapeuticsAXSM · Health Care | -6.50% | TRY 360.9B | TRY 6,861.55 | 1.25% up | 6% down | ||
| 33 | Corcept TherapeuticsCORT · Health Care | -9.67% | TRY 359.6B | TRY 3,286.14 | 4.15% down | 10% down | ||
| 34 | Abbott LaboratoriesABT · Health Care | -15.7% | TRY 9.1T | TRY 5,252.87 | 0.58% down | 16% down | ||
| 35 | CytokineticsCYTK · Health Care | -19.2% | TRY 362.5B | TRY 2,602.41 | 0.27% up | 19% down | ||
| 36 | Cogent BiosciencesCOGT · Health Care | -19.9% | TRY 244.1B | TRY 1,402.86 | 0.25% down | 20% down | ||
| 37 | PTC TherapeuticsPTCT · Health Care | -21.2% | TRY 246.4B | TRY 2,949.59 | 3.16% down | 21% down | ||
| 38 | ZoetisZTS · Health Care | -26.2% | TRY 1.66T | TRY 4,085.68 | 5.59% down | 26% down | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | TRY 466.1B | TRY 20,063.78 | 0.34% down | 27% down | ||
| 40 | Summit TherapeuticsSMMT · Health Care | -36.2% | TRY 427.5B | TRY 534.54 | 0.67% up | 36% down | ||
| 41 | InsmedINSM · Health Care | -40.0% | TRY 1.6T | TRY 7,305.57 | 20.58% up | 40% down | ||
| 42 | Legend BiotechLEGN · Health Care | -41.0% | TRY 157.9B | TRY 814.20 | 0.92% down | 41% down | ||
| 43 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | TRY 229.3B | TRY 1,376.56 | 0.62% down | 63% down | ||
| 44 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | TRY 1T | TRY 7,475.49 | 1.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 50.5716 TRY).
Questions and answers
Which pharmaceutical companies in the United States rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 44 pharmaceutical companies in the United States ranked by one-year price change as of 20 Nov 2026, 07:26 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by one-year price change.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by one-year price change have a combined market value of TRY 188.93T as of 20 Nov 2026, 07:26 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by one-year price change”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.